Delray Medical Center recently began using the Spiration valve system for the treatment of severe emphysema along with SeleCT screening, an AI-screening program powered by Imbio, with Dr. Stephen Milan performing the procedure.
“We are pleased to add the Spiration valve system to our treatment options for patients with severe emphysema and SeleCT screening as a tool that may help our physicians more easily identify the patients best suited for this treatment,” said Milan. “SVS from Olympus gives pulmonologists at Delray Medical Center an additional treatment alternative for this underserved patient population. Meaningful improvement in breathing can mean fuller lives for our patients.”
FAU researchers aid study of young kids, screen time
In a new study, researchers at Florida Atlantic University and Aarhus University in Denmark studied 546 4- to 5-year-old children from 24 child care centers in Denmark for six months. They measured their language skills, behavior and the amount of time the children spent watching screens alone.
The study findings, published in the journal Research on Child and Adolescent Psychopathology, found that spending screen time alone made behavior problems worse for children with poor communication skills and weak vocabularies.
The results highlighted the importance of the home learning environment and showed that time spent alone with a screen does not replace helpful social interactions with parents and peers.
JFK Hospital part of group receiving award for safety
HCA Florida Healthcare announced that 36 of its hospitals, including JFK Hospital in Atlantis, received the 2026 Patient Safety Excellence Award from Healthgrades, placing the network among the top 10% nationwide for patient safety.
FAU scientists determine how brain disease worsens
Huntington’s disease is an inherited brain illness where a harmful protein builds up and moves from one brain cell to another. Over the course of 10 to 20 years, this causes worsening movement problems, thinking difficulties and mood issues. There’s no cure now; current treatments only ease symptoms.
In a new study published in Science Advances, Florida Atlantic University scientists and collaborators have found how the bad protein spreads: Brain cells make tiny tube-like bridges to pass it along. The team discovered that two proteins, called Rhes and SLC4A7, work together to form those bridges. When researchers blocked this in lab cells in mice, the protein spread much less.
This points to a new way to try to slow or stop Huntington’s disease.
— Christine Davis
Comments